Publication:
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung

Simple item page
dc.contributor.authorMoreo, Eduardo
dc.contributor.authorJarit-Cabanillas, Aitor
dc.contributor.authorRobles-Vera, Iñaki
dc.contributor.authorUranga, Santiago
dc.contributor.authorGuerrero, Claudia
dc.contributor.authorGómez, Ana Belén
dc.contributor.authorMata-Martínez, Pablo
dc.contributor.authorMinute, Luna
dc.contributor.authorAraujo-Voces, Miguel
dc.contributor.authorFelgueres, María José
dc.contributor.authorEsteso, Gloria
dc.contributor.authorUranga-Murillo, Iratxe
dc.contributor.authorArias, Maykel
dc.contributor.authorPardo, Julián
dc.contributor.authorMartín, Carlos
dc.contributor.authorValés-Gómez, Mar
dc.contributor.authordel Fresno, Carlos
dc.contributor.authorSancho, David
dc.contributor.authorAguiló, Nacho
dc.date.accessioned2023-11-21T11:26:14Z
dc.date.available2023-11-21T11:26:14Z
dc.date.issued2023
dc.description.peerreviewedSíes_ES
dc.description.sponsorshipThis work was supported by MCIN/AEI/10.13039/501100011033 [grants number RTI2018-097625-B-I00 and PID2022-138624OB-I00], Gobierno de Aragón [grant number LMP50_21] and Asociación Española Contra el Cáncer (AECC) [grant number IDEAS211042AGUI]. NA was the principal investigator of all these grants. This research was supported by CIBER -Consorcio Centro de Investigación Biomédica en Red- (Groups CB06/06/0020 and CB21/13/00087), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – European Regional Development Fund. DS laboratory is funded by the CNIC; by the European Union’s Horizon 2020 research and innovation program under grant agreement ERC-2016-Consolidator Grant 725091; by MCIN PID2019-108157RB MCIN/AEI/10.13039/501100011033 and CPP2021- 008310 MCIN/AEI/10.13039/501100011033 Unión Europea Next GenerationEU/PRTR; by Comunidad de Madrid (P2022/BMD-7333 INMUNOVAR-CM); and by “la Caixa” Foundation (LCF/PR/HR20/00075 and LCF/PR/HR22/00253).The laboratory of C.d.F. is funded by Instituto de Salud Carlos III (ISCIII) through the projects CP20/00106 and PI21/01178 and co-funded by the European Union. The laboratory of M.V-G. is funded by Spanish Ministry of Science and Innovation [grant number PID2021-123795OB-I00]. C.G. has a pre-doctoral fellowship from Gobierno de Aragón. M.J.F. is PhD Candidate at the Autonomous Madrid University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Authors acknowledge the Scientific and Technical Services from Instituto Aragonés de Ciencias de la Salud (IACS) and Universidad de Zaragoza.es_ES
dc.format.number1es_ES
dc.format.volume14es_ES
dc.identifier.citationNat Commun. 2023 Oct 4;14(1):6090.es_ES
dc.identifier.doi10.1038/s41467-023-41768-8es_ES
dc.identifier.e-issn2041-1723es_ES
dc.identifier.journalNature Communicationses_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16704
dc.language.isoenges_ES
dc.publisherNature Publishing Groupes_ES
dc.relation.publisherversion10.1038/s41467-023-41768-8es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Inmunobiologíaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleIntravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lunges_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationc56ae6c1-121b-4e6c-ab1c-ae787f8622f2
relation.isAuthorOfPublication58aa2591-8084-4500-bfe4-8f2c54e398e9
relation.isAuthorOfPublication.latestForDiscoveryc56ae6c1-121b-4e6c-ab1c-ae787f8622f2

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Intravenous administration_Nat Commun_2023.pdf
Size:
4.87 MB
Format:
Adobe Portable Document Format
Description:
Artículo
Download

Collections

Grupos de investigación